Dasatinib

Brand name: Sprycel

Rank #123 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$136.8M

Total Cost

Share:

10,389

Total Claims

$136.8M

Total Cost

591

Prescribers

$13K

Cost per Claim

0

Beneficiaries

10,485

30-Day Fills

$231K

Avg Cost/Provider

18

Avg Claims/Provider

Share of Medicare Part D Spending

0.05%

of total Medicare Part D spending

$136.8M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $136.8M total

🔎 Data Overview

💰

At $13,168 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $231,475 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Dasatinib

#ProviderSpecialtyLocationClaimsCost
1Lucy WedowNurse PractitionerRochester, NY74$1.0M
2Alexis Cruz-ChaconHematology-OncologySan Juan, PR65$1.0M
3Todd RosenblatHematologyNew York, NY55$966K
4Heather FoxPhysician AssistantAnn Arbor, MI53$785K
5Muay Hernandez PonsHematology-OncologyCaguas, PR40$683K
6Graciany MirandaHematology-OncologyHumacao, PR63$647K
7Daniel DeangeloMedical OncologyBoston, MA49$644K
8Adam AschHematology-OncologyOklahoma City, OK52$633K
9Nelson Matos-FernandezHematology-OncologySanta Isabel, PR46$616K
10Kenel Fernandes BarbosaHematology-OncologyBayamon, PR35$604K
11Joseph LebowiczHematology-OncologyBrooklyn, NY43$588K
12Craig BoddyHematology-OncologyHonolulu, HI40$583K
13Lauren VeltriHematology-OncologyMorgantown, WV37$582K
14Erin PettijohnHematology-OncologyGrand Rapids, MI47$572K
15Ashwin ChandarHematologyNew Brunswick, NJ32$570K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology